BioSig Technologies, Inc. (BSGM) Insider Trading Activity

NASDAQ$6.035-0.35 (-5.48%)
Market Cap
$174.41M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
473 of 872
Rank in Industry
60 of 109

BSGM Insider Trading Activity

BSGM Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About BioSig Technologies, Inc.

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Insider Activity of BioSig Technologies, Inc.

Over the last 12 months, insiders at BioSig Technologies, Inc. have bought $0 and sold $0 worth of BioSig Technologies, Inc. stock.

On average, over the past 5 years, insiders at BioSig Technologies, Inc. have bought $303,853 and sold $530,371 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 15,600 shares for transaction amount of $19,358 was made by LONDONER KENNETH L (Chief Executive Officer) on 2023‑06‑13.

List of Insider Buy and Sell Transactions, BioSig Technologies, Inc.

2023-06-13PurchaseLONDONER KENNETH LChief Executive Officer
15,600
0.025%
$1.24
$19,358
-72.90%
2023-06-12PurchaseLONDONER KENNETH LChief Executive Officer
6,000
0.0094%
$1.17
$7,040
-71.84%
2023-06-02PurchaseLONDONER KENNETH LChief Executive Officer
4,600
0.0078%
$1.37
$6,292
-72.80%
2023-05-31PurchaseLONDONER KENNETH LChief Executive Officer
8,000
0.0132%
$1.57
$12,560
-76.61%
2023-02-08PurchaseBUHALY STEVEN JChief Financial Officer
232,882
0.0003%
$0.86
$199,999
-44.44%
2022-09-07PurchaseLONDONER KENNETH LChief Executive Officer
1,000
0.0022%
$0.83
$830
+5.49%
2022-09-02PurchaseLONDONER KENNETH LChief Executive Officer
1,000
0.002%
$1.00
$1,000
-19.50%
2022-09-01PurchaseLONDONER KENNETH LChief Executive Officer
17,240
0.0368%
$1.08
$18,704
-22.12%
2022-09-01PurchaseCHAUSSY STEVEChief Financial Officer
11,425
0.0254%
$1.13
$12,929
-22.12%
2022-08-30PurchaseSieckhaus JohnChief Operating Officer
5,000
0.0113%
$1.07
$5,335
-16.19%
2022-08-29PurchaseLONDONER KENNETH LChief Executive Officer
6,100
0.0137%
$1.10
$6,710
-18.99%
2022-08-25PurchaseLONDONER KENNETH LChief Executive Officer
1,000
0.0022%
$1.12
$1,120
-23.04%
2022-08-24PurchaseGallagher Patrick Joseph
17,000
0.0391%
$1.16
$19,720
-20.27%
2022-08-24PurchaseSieckhaus JohnChief Operating Officer
10,000
0.0225%
$1.13
$11,347
-20.27%
2022-08-24PurchaseFleming GrayChief Commercial Officer
36,036
0.0843%
$1.18
$42,522
-20.27%
2022-08-23PurchaseLONDONER KENNETH LChief Executive Officer
2,000
0.0046%
$1.10
$2,200
-15.70%
2022-08-22PurchaseCHAUSSY STEVEChief Financial Officer
8,000
0.0175%
$1.13
$9,016
-19.65%
2022-08-19PurchaseLONDONER KENNETH LChief Executive Officer
4,000
0.0085%
$1.00
$4,000
-10.86%
2022-08-17PurchaseLONDONER KENNETH LChief Executive Officer
6,000
0.0137%
$0.99
$5,940
+0.10%
2022-08-16PurchaseLONDONER KENNETH LChief Executive Officer
4,100
0.0088%
$0.96
$3,936
-2.53%
Total: 240

Insider Historical Profitability

3.93%
Mikolaitis Lora10 percent owner
3077474
11.275%
$19.67M02
LONDONER KENNETH LChief Executive Officer
2507020
9.185%
$16.02M10875
<0.0001%
CHAUSSY STEVEChief Financial Officer
1051553
3.8526%
$6.72M230
+18.04%
FOLEY DONALD Edirector
255000
0.9343%
$1.63M20
+26.76%
BUHALY STEVEN JChief Financial Officer
232882
0.8532%
$1.49M10
<0.0001%
ODONNELL JEFFREY Fdirector
151629
0.5555%
$968,909.3112
Kowalski John MVP of Sales
112000
0.4103%
$715,680.0030
+89.76%
ZELDIS JEROME Bdirector
107944
0.3955%
$689,762.1610
<0.0001%
Gallagher Patrick Joseph
100000
0.3664%
$639,000.0050
+15.81%
Sieckhaus JohnChief Operating Officer
65000
0.2381%
$415,350.0020
<0.0001%
Filler Andrew Lawrencedirector
56518
0.2071%
$361,150.0230
+11.17%
Fleming GrayChief Commercial Officer
36036
0.132%
$230,270.0410
<0.0001%
Tanaka Roy Tdirector
30000
0.1099%
$191,700.0010
Pease Marthadirector
9437
0.0346%
$60,302.4370
+9.12%
Rafferty JosephChief Commercialization Offcr
7000
0.0256%
$44,730.0010
+28.57%
NAVARRO SAMUEL Edirector
3500
0.0128%
$22,365.0020
<0.0001%

BSGM Institutional Investors: Active Positions

Increased Positions14+77.78%7M+156.71%
Decreased Positions2-11.11%131,061-2.98%
New Positions5New4MNew
Sold Out Positions<1Sold Out41,000Sold Out
Total Postitions30+66.67%11M+153.73%

BSGM Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Legacy Wealth Managment, Llc/Id$4,936.0015.01%3.6M+4MNew2024-12-31
Legacy Investment Solutions, Llc$4,936.0015.01%3.6M+4MNew2024-12-31
Rossby Financial, Lcc$618.001.88%451,130+172,000+61.62%2025-03-31
Cambridge Investment Research Advisors, Inc.$365.001.11%266,435+241,447+966.25%2025-03-31
Pfg Investments, Llc$217.000.66%158,286+48,000+43.52%2025-03-31
Millennium Management Llc$210.000.64%153,207+153,207New2024-12-31
Geode Capital Management, Llc$131.000.4%95,733+95,733New2024-12-31
Integrity Wealth Advisors, Inc.$56.000.17%41,000+41,000New2024-12-31
Ubs Group Ag$32.000.1%23,121+23,121New2024-12-31
Two Sigma Securities, Llc$20.000.06%14,853+14,853New2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.